BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 15734758)

  • 1. Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome.
    Bokal EV; Vrtovec HM; Virant Klun I; Verdenik I
    Hum Reprod; 2005 Jun; 20(6):1562-8. PubMed ID: 15734758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
    Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
    Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine arterial blood flow and the substances of ovarian renin-angiotensin system in women with polycystic ovaries undergoing in vitro fertilization.
    Vrtacnik-Bokal E; Meden-Vrtovec H; Verdenik I
    Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):77-81. PubMed ID: 16183189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
    Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
    Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF.
    Artini PG; Ruggiero M; Parisen Toldin MR; Monteleone P; Monti M; Cela V; Genazzani AR
    Hum Fertil (Camb); 2009 Mar; 12(1):40-4. PubMed ID: 19330612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
    Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval.
    Raziel A; Schachter M; Strassburger D; Kasterstein E; Ron-El R; Friedler S
    Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine concentrations in follicular fluid are associated with poor oocyte and embryo qualities in polycystic ovary syndrome patients undergoing assisted reproduction.
    Berker B; Kaya C; Aytac R; Satiroglu H
    Hum Reprod; 2009 Sep; 24(9):2293-302. PubMed ID: 19443458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
    Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
    Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment.
    Chian RC; Buckett WM; Abdul Jalil AK; Son WY; Sylvestre C; Rao D; Tan SL
    Fertil Steril; 2004 Dec; 82(6):1675-8. PubMed ID: 15589878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
    Kdous M; Chaker A; Zhioua A; Zhioua F
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction.
    Cerrillo M; Rodríguez S; Mayoral M; Pacheco A; Martínez-Salazar J; Garcia-Velasco JA
    Fertil Steril; 2009 Apr; 91(4 Suppl):1526-8. PubMed ID: 18990367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.
    Hossein G; Arabzadeh S; Hossein-Rashidi B; Hosseini MA
    Gynecol Endocrinol; 2012 Jun; 28(6):413-7. PubMed ID: 21992510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist.
    Cunha-Filho JS; Lemos N; Stein N; Laranjeira A; Passos EP
    Fertil Steril; 2005 Apr; 83(4):902-7. PubMed ID: 15820798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome.
    Chian RC; Buckett WM; Tulandi T; Tan SL
    Hum Reprod; 2000 Jan; 15(1):165-70. PubMed ID: 10611207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of follicular fluid prorenin to oocyte maturation, steroid levels, and outcome of in vitro fertilization.
    Itskovitz J; Rubattu S; Rosenwaks Z; Liu HC; Sealey JE
    J Clin Endocrinol Metab; 1991 Jan; 72(1):165-71. PubMed ID: 1986016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.